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1. Introduction 
Neurodegenerative diseases form a subset of pathologies that are characterized by a 
progressive and specific loss of neurons paralleled by the emergence of misfolded proteins 
in various cell types, the significance of which is still highly debated (Harris et al. 2009). 
These pathological traits result in mixed impairments of motor, cognitive and psychological 
functions (Harris et al. 2009). Parkinson’s disease (PD), which is characterized by a 
prominent loss of dopaminergic neurons and the formation of Lewy bodies - nuclear 
inclusions largely composed of α-synuclein - is the second neurodegenerative disorder in 
importance after Alzheimer’s disease.  
The prevalence of PD increases exponentially between 65 and 90 years of age. 
Approximately 0.3% of PD cases are found in the general population as opposed to 3% in 
individuals over 65 (Moghal et al. 1994). While a very small fraction of PD is related to 
monogenic mutations, over 90% of cases are likely linked to environmental causes (referred 
to as idiopathic PD), suspected to be in part related to well-water consumption, exposure to 
heavy metals and pesticides (De Michele et al. 1996; Schapira 1996; Tanner et al. 1999) 
(Table 1). Recent work conducted in animal models has suggested that the onset of the  
 
 
 
Table 1. Potential environmental risk factors for Parkinson’s disease 
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disease later in life may derive from various non-exclusive scenarios, namely chronic 
exposure to low levels of neurotoxicants, time-limited exposure early in life with later 
manifestation due to the decline of certain brain cell populations with advanced aging, 
and/or increased sensitivity to exposure with advanced age (see (Di Monte et al. 2002)). 
These hypotheses are particularly relevant to the interpretation of the epidemiological data 
gathered over the years and which will be reviewed in this chapter.  
1.1 Clinical and pathological features of Parkinson’s disease 
One of the challenging aspects of PD is the heterogeneous nature and variability of the 
symptomatology and pathology (Lewis and Barker 2009). Two main subtypes of the disease 
have emerged from clinical observations based on the age of onset and the 
evolution/progression of the disease. While the disease in younger patients is rather 
typified by symptoms of resting tremors, older patients are more likely to suffer from 
“postural imbalance and gait disorders” (Selikhova et al. 2009). These disparate clinical 
manifestations may reflect various etiologies derived from interactions between genetic and 
environmental factors. While this disorder has for long been viewed for its predominant 
motor deficits, a much more complex scheme of the pathophysiology is being unveiled, and 
includes several non-motor features such as cognitive impairments, depression, anxiety and 
sleep-related disturbances (see Figure 1). The nature and diversity of the handicaps caused 
  
 
Fig. 1. Current views of the etiology and pathology of Parkinson’s disease 
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by PD make it a very debilitating condition. The long-standing history and research devoted 
to the motor impairments of the disease have revealed that they result, in large part, from a 
loss of a specific subpopulation of dopaminergic neurons within the basal ganglia, a subset 
of brain structures involved in the control of psychomotor behaviors. Conversely, the non-
motor alterations observed in PD have been related, for example, to the loss of non-
dopaminergic cells, such as the noradrenergic (Zarow et al. 2003), serotoninergic (Braak et 
al. 2004) and cholinergic neurons of various other brain nuclei (Figure 1). PD is also 
characterized by a synucleinopathy, another pathological hallmark which consists in the 
entanglement of the mutated form of α-synuclein, which leads to Lewy body formation 
further postulated to cause cell damage by impairing neuronal functions (Waxman and 
Giasson 2009). 
2. Is pesticide exposure a risk factor for Parkinson’s disease? 
2.1. Evidence from epidemiological studies 
The historical observations, in the late 70’s, of the sudden appearance of parkinsonism in 
seven young individuals exposed to 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP) 
contaminated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Langston et al. 
1983) gave birth to the notion of a potential link between environmental factors and the 
development of PD. MPTP itself does not pose a likely exposure risk for the general 
population. However, MPTP bears striking similarities to other naturally occurring as well 
as manmade substances, namely the heavily used pesticides rotenone and paraquat. The 
specific relationship between exposure to pesticides and the development of PD has 
received increasing attention since the early 80’s, when Barbeau discussed the association 
between manganese or MPTP intoxication and the pathogenesis of this disorder. He 
proposed that individuals being frequently exposed to environmental compounds bearing 
chemical conformations similar to MPTP could develop comparable parkinsonism 
syndromes (Barbeau, 1984). A few years later, he reported his observations of an association 
between living in an agricultural environment and the risk of developing PD in the province 
of Quebec, Canada, where pesticide use was strikingly high at the time (Barbeau et al. 1987). 
While the epidemiological studies published in the last three decades have raised awareness 
of the potential health issues related to pesticide-promoted agriculture, they have not 
indisputably demonstrated a specific relationship between these toxins and the 
development of PD. In the following sections, we will attempt to shed light on the 
investigations published since 1989, discussing both the positive evidence and the lack of 
association between pesticide exposure and neurodegeneration.  
2.1.1 Pesticides and Parkinson’s disease: Positive associations from retrospective 
studies  
Evidence tying pesticide use and PD has surfaced from all over the world, although the 
identification of specific compounds under this general heading has been more complex. 
Considering this important limitation, dithiocarbamates and pesticides of the 
organochlorine family of insecticides have been the targets of the vast majority of 
retrospective case-control studies conducted to date. Despite small sample sizes, a large 
number of these inquiries have revealed a positive correlation between pesticide contact and 
PD. Such observations were made in nursing homes for elderly in two Hong Kong districts, 
where 3.4% of these residents (> 60 years) suffered from PD (odds ratio (OR) = 3.6; 95% 
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confidence interval (CI) 1.0-12.9)1 (Ho et al. 1989). The results of another study involving 106 
patients diagnosed with PD (their spouses serving as controls), showed that patients had 
significantly greater rural experience and were more likely to have routinely sprayed 
pesticides in comparison to their partners (OR = 7.0, p < 0.05) (Golbe et al. 1990). In a 
population-based case-control study comprising 130 PD subjects living in Calgary and 260 
randomly selected age- and sex-matched community controls, herbicide (OR = 3.06; 95% CI 
1.34-7.00, p = 0.006) and insecticide use (OR = 2.05; 95% CI 1.03-4.07, p = 0.042) (but not 
fungicide) were found to be significant predictors of PD, after controlling for confounding 
factors or interactions between the exposure variables (Semchuk et al. 1992). A link between 
herbicide exposure and PD (OR = 3.22, p = 0.033) was also found in young onset PD patients 
(i.e. diagnosed before the age 50) as compared to controls diagnosed with rheumatoid 
arthritis (Butterfield et al. 1993) (see Table 2 for details).  
In the late 90’s, three additional studies reported a connection between the risk of 
developing PD and exposure to pesticides. In a Hong Kong hospital-based, case-control 
study regrouping 215 PD cases and 313 controls, the duration of exposure to farm pesticides 
correlated with increased PD risk (multivariate analysis). Pesticide exposure in women 
conducting farming activities (OR = 6.84; 95% CI 1.90-24.7; p = 0.003) was also found, 
although this was not the case for men. It should be noted that sample sizes were very small 
(6 men and 13 women with PD; 13 control men and 3 women) (Chan et al. 1998). In a 
population-based case-control study referring to a cohort of men and women over 50 pooled 
from medical centers of metropolitan Detroit (144 PD cases and 464 controls), a significant 
association between occupational exposure to herbicides (OR = 4.10; 95% CI 1.37-12.24) or 
insecticides (OR = 3.55; 95% CI 1.75-7.18) was reported. However, no relation was found 
again with regard to fungicide exposure (Gorell et al. 1998). In 1999, a case-control study 
conducted in southeastern Sweden and involving the participation of 113 idiopathic PD 
cases and 263 control subjects reported an increased risk of idiopathic PD in men (10 men 
with PD and 10 men in controls had a history of handling pesticides), which was associated 
with agricultural labor and pesticide contact (OR = 2.8; 95% CI 0.89–8.7) (Fall et al. 1999). 
                                                 
1 A relative risk (RR) is a comparative measure of the observed risk of developing PD in individuals 
who are exposed to pesticides vs. the observed risk of developing PD in a group of ”equivalent” 
subjects who were not exposed. A RR of 1.0 indicates that there is no increased risk. Using 1.0 as the 
benchmark, a reported RR of, for example, 1.34 may indicate that the PD risk from pesticide exposure is 
0.34 or 34% higher. However, for the result to be taken into consideration, the RR has to achieve 
statistical significance, using confidence interval (CI) levels. The generally agreed upon confidence level 
is 95%, where there is a 5% chance that the significant result is due to the random luck of draw. The CI 
implies that there is a 95% probability that the “real” RR lies anywhere in the range between the 
numbers of the interval. The CI is affected by sample size and by variability among subjects. This 
signifies that the findings are statistically significant only when the lower number of the interval 
exceeds 1.0. Additionally, the narrower is the interval, the more statistical power there is to the result. 
When the higher number of the interval is below 1.0, pesticide exposition is either not associated to PD, 
or is protective against PD. Any RR rating of less than 2 is very weak, difficult to interpret and very 
likely to be due to either bias, confounding factors or chance. Case-control studies often prevent you 
from evaluating a RR, but the odd ratio (OR) can always be calculated and interpreted. A case-control 
design usually involves the selection of research subjects on the basis of having PD rather than on the 
basis of having been exposed to pesticide. The probability of developing PD in pesticide-exposed 
subjects can be estimated, but not the probability of being exposed to pesticides when you have PD. The 
OR offers a reasonable interpretation, as long as the outcome event is rare and its interpretation rely 
strongly on how the controls were recruited, and is usually higher than the RR. 
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An additional number of retrospective studies reporting a relationship between pesticide 
exposure and PD were conducted after 2000. Using a cohort of 310 men, mostly orchardists 
who had previously participated in a cohort study of men occupationally exposed to 
pesticides in Washington State, Engel et al. (2001a) found a significant association for older 
subjects exposed to pesticides (Prevalence ratio (PR) = 2.0; 95% CI 1.0-4.2). Similar results 
were obtained for the middle tertile but did not reach statistical significance (PR = 1.9; 95% 
CI 0.9-4.0). However, no specific pesticide, or classes of pesticides, were associated with an 
increased risk of having PD (Engel et al. 2001a). In another study in Israel, the second 
strongest predictor of PD risk in 93 PD patients living in cities and 93 age- and sex- matched 
controls was exposure to pesticides (OR = 6.34; 95% CI 0.75-53.8, p = 0.06) (Herishanu et al. 
2001). A subsequent case-control study performed in northeastern Italy and composed of 
136 PD cases and 272 controls affected by other neurological diseases reported a positive 
association between pesticide exposure and PD (crude OR = 2.0; 95% CI 1.1-3.5, p = 0.0237). 
The mean length of exposure to pesticides was also significantly different in these cases, as 
compared to control subjects (4.1 years, standard deviation (SD) = 10.9 and 2 years, SD = 6.4, 
respectively; p < 0.05) (Zorzon et al. 2002). Gender differences were also outlined in a study 
involving 113 prevalent cases of PD. Multivariate analyses were independently performed 
for men and women, and ownership of licenses for pesticide use was positively associated 
with PD, but only in men (OR = 3.68; 95% CI 1.57–8.64) (Baldereschi et al. 2003). A 
population-based study in a genetically isolated community in a rural area of Turkey 
pointed to an increase in the prevalence of parkinsonism (4.1%) in individuals ≥ 65 years of 
age (36 cases of parkinsonism and 108 age- and sex-matched community controls). In this 
cohort, pesticide exposure was significantly associated with parkinsonism (OR = 2.96; 95% 
CI 1.31-6.69, p = 0.015) (Duzcan et al. 2003). An increased prevalence in men was also 
demonstrated (OR = 2.4; 95% CI, 1.1-5.4; p = 0.04) in a cohort that included every PD 
patients in Olmsted County (MN), from 1976 through 1995. Cases were matched to general 
population controls for age and gender (Frigerio et al. 2006) (see Table 2 for details and 
Figure 2 for geographical mapping of studies conducted).  
In counterpart to the positive association of the use of pesticide per se and the occurrence of 
PD, the authors of another case-control study conducted in British Columbia (Canada), and 
involving 127 PD cases and 245 controls (121 with cardiac disease and 124 randomly 
selected from electoral registers) established a significant association between idiopathic PD 
in men practicing a profession in which exposure to pesticides was highly probable (OR = 
2.32; 95% CI 1.10-4.88). However, they considered occupational exposure to several 
chemicals, including organochlorines, organophosphates, carbamates and dithiocarbamates, 
but none of these chemicals alone were connected with idiopathic PD (Hertzman et al. 1994). 
The authors concluded that the pathogenesis of PD is more likely to be multifactorial, thus 
excluding the possibility of a single-agent hit.  
2.1.2 Pesticides and Parkinson’s disease: Lack of association from retrospective 
studies 
A comparable number of retrospective epidemiological studies have failed to identify a 
relationship between pesticide exposure and the risk of developing PD. In a case-control 
study using 150 PD cases from a Kansas movement disorder clinic and 150 age- and sex-
matched controls attending other neurological and medical centers, no significant difference 
in the incidence of PD was detected for exposure to herbicides or pesticides with respect to 
the number of years of exposure, type of herbicide or pesticide, circumstances of exposure, 
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surface of land or type of crops on which herbicides/pesticides were employed, except for a 
marginal significance for exposure to herbicides/pesticides sprayed on corn (Koller et al. 
1990). In another case-control study in which 42 PD subjects were matched to 84 controls of 
the Community Health Department of Valleyfield (Quebec, Canada), pesticide handling did 
not relate to PD. Oddly, other factors frequently identified as risk factors for PD, such as 
living in rural (OR = 0.31; 95% CI 0.11-0.91, p < 0.05) or industrial areas or working in mines 
(OR = 0.15; 95% CI 0.04-0.55, p < 0.05), were associated with a decreased risk for being struck 
with the disease (Zayed et al. 1990). Another case-control study using a cohort of 80 patients 
with late-onset PD (> 60 years old) and 69 early-onset patients (< 40 years old) recruited 
from various American hospitals, and 149 age- and sex-matched control subjects selected by 
the case subjects (relatives and spouses were not eligible) or from hospital files failed to 
implicate exposure to herbicides or pesticides in the incidence of PD (Stern et al. 1991). 
Moreover, in a case-control study involving 19 families harboring two or more PD cases, 
and 38 controls, herbicide and pesticide exposure was not a significant risk factor, although 
statistically significant differences were found with the following factors: rural residence, 
well-water consumption and farming (Wong et al. 1991). Additionally, in a study realized in 
a selected urban area of Madrid, among 128 unselected PD patients and 256 age- and sex-
matched controls, past exposure to pesticides (for at least one year) and duration of 
exposure was apparently not associated with an increased risk of developing PD (Jimenez-
Jimenez et al. 1992) (see Table 2 for details and Figure 2 for geographical mapping of  
studies conducted).  
In South East Queensland and Central West New South Wales in Australia, a case-control 
study involving 224 PD cases and 310 control subjects reported no significant difference 
between patients and controls for exposure to herbicides and pesticides, but rural residence 
emerged as a significant risk factor for PD (McCann et al. 1998). Furthermore, exposure to 
pesticides and herbicides was similar between 86 PD cases and 86 matched controls, which 
were all outpatients from the same hospital (Smargiassi et al. 1998), and between 140 PD 
cases who were recruited from the Boston University Medical Center, where 147 friends and 
in-laws served as control subjects (Taylor et al. 1999). One other study undertaken in 1999 
failed to detect an association between herbicide and pesticide exposure and PD, which 
consisted in a community-based case-control study in rural municipalities of the 
southwestern part of Finland using 123 PD cases and 246 matched control subjects (Kuopio 
et al. 1999). Additionally, no risk association was found with pesticide and/or herbicide 
contact in a case-control study in the Limousin region of France, using a cohort composed of 
140 PD patients and 280 age-matched control subjects. The duration of exposure to 
pesticides or herbicides, however, was not determined (Preux et al. 2000).  
More recently, a population-based case-control study using a cohort of 250 idiopathic PD 
cases and 388 healthy control subjects derived from a health care system database in western 
Washington State and the University of Washington, observed no significant association 
between occupational exposure and PD, but suggested a gradient of risk for occupational 
titles that paralleled the predicted level of pesticide exposure (e.g. pesticide worker > crop 
farmer > combined animal and crop farmer > dairy farmer) (OR = 2.07; 95% CI 0.67-6.38). 
ORs were also elevated for herbicides (OR = 1.41; 95% CI 0.51-3.88) and particularly 
paraquat (OR = 1.67; 95% CI 0.22-12.76), but there was no evidence of risk for exposure to 
pesticides used on a home basis (Firestone et al. 2005). The same group reported that the risk 
of PD was not significantly associated with exposure to pesticides in general. When 
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exploring specific pesticides, the only increased risk trend was for men exposed to 
parathion, the most potent organophosphate known, although this was not statistically 
significant. The cohort was composed of 404 idiopathic PD cases and 526 controls (Firestone 
et al. 2010). In New Delhi, India, a case-control study involving 377 PD patients attending a 
movement disorder clinic and an equal number of outpatients with other neurological 
diseases, did not report any significant correlation between the occurrence of PD and 
exposure to insecticides, herbicides and rodenticides. Nevertheless, exposure to herbicides 
was increased among control subjects (Behari et al. 2001). This is, to our knowledge, the only 
report of a trend towards a negative correlation between pesticide use and PD, although it 
did not reach statistical significance.  
Taken together, the results of the retrospective epidemiological analyses are inconsistent, 
which reflects the great variability in the methodologies employed and the increased bias 
inherent to self-report studies. In addition, most of the studies described above used a 
relatively small number of subjects, with an even smaller number of subjects presenting a 
past history of pesticide exposure. This drawback considerably decreases statistical power 
and therefore limits the relevant analyses. Overall, despite the large number of retrospective 
studies conducted in the past 20 years, the association between pesticide/herbicide 
exposure and the increased risk of PD remains inconclusive, although the available evidence 
tends to suggest that pesticide exposure plays a role in some idiopathic forms of the disease. 
2.1.3 From the angle of prospective studies and meta-analysis  
In an attempt to eliminate recall bias, some epidemiological studies have used a prospective 
approach. The first study conducted in such a manner analyzed the relationship between 
exposure to pesticides and an increased risk of developing PD 30 years following the 
determined moment of initial pesticide exposure. Among the 7 986 participants in a cohort 
of Hawaiian plantation workers, 116 men were diagnosed with PD during the 30-year 
follow-up, with a significantly increased incidence among men who worked for more than 
10 years on a plantation. Despite the fact that age-adjusted incidence of PD was higher in 
men exposed to pesticides, in comparison with those spared from pesticide exposure, this 
analysis did not reach statistical significance (Petrovitch et al. 2002). Another prospective 
cohort study - of 1 507 French elderly - used a job exposure matrix to assess occupational 
exposure and revealed that subjects who had been occupationally exposed to pesticides 
exhibited lower cognitive performance. The authors of this study further reported that 
exposure to pesticides increased the relative risk of developing PD in men (OR = 5.63; 95% 
CI 1.47-21.58), but not in women, after confounding factors (smoking and education level) 
were taken into account (Baldi et al. 2003b). In a subsequent study focusing specifically on 
PD and using 84 PD cases and 252 population-based controls belonging to the same French 
elderly cohort, a positive association was observed with occupational pesticide exposure 
(OR = 2.2; 95% CI 1.1-4.3). However, no clear dose-response relationship was found (Baldi et 
al. 2003a). Using participants enrolled in the Cancer Prevention Study II Nutrition Cohort, 
Ascherio et al. (2006) reexamined whether individuals exposed to pesticides expressed a 
higher risk for PD. In 1982, participants completed a survey concerning occupation and 
exposure to selected chemicals or dusts, including pesticides. After follow-up surveys in 
1997, 1999, and 2001, 7 864 participants reported exposure to pesticides, of which 1 956 were 
farmers, ranchers, or fishermen, thereby revealing a 70% higher incidence of PD in 
individuals exposed to pesticides (adjusted relative risk (RR), 1.7; 95% CI 1.2-2.3; p = 0.002). 
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The RR for pesticide exposure was similar in farmers and non-farmers. No relation was 
found between risk for PD and any of the other occupational exposures surveyed (e.g. 
asbestos, chemicals/acid solvents, coal and stone dust, dyes, gasoline exhaust) (Ascherio et 
al. 2006) (see Table 2 for details and Figure 2 for geographical mapping of studies 
conducted). 
In 2000, Priyadarshi and colleagues conducted a meta-analysis encompassing 19 studies 
published between 1989 and 1999. When all studies were combined, the OR for PD risk in 
association with pesticide exposure was 1.94 and 2.15 for studies performed in the United 
States alone, corresponding to a 2-fold risk increase. The risk of PD increased with duration 
of exposure, but no significant dose-response relationship was established and no specific 
type of pesticides was identified (Priyadarshi et al. 2000). The consistency of the results 
obtained in the studies selected for this meta-analysis allowed the authors to conclude that 
exposure to pesticides may be a risk factor for PD, independently of the place where the 
study was conducted.  
2.1.4 Additional types of analyses  
Other methodologies have been employed to assess the possible link between pesticide 
exposure and PD. For example, one study used a proportional odds model for survival data 
comparing all PD cases that were recorded as underlying or associated causes of death 
occurring in California, with all deaths from ischemic heart disease during the same period. 
They further classified Californian counties into several pesticide use categories based on 
data from pesticide use reports. Results showed that mortality from PD as the underlying 
cause of death was higher in counties in the category of agricultural pesticide use. 
Moreover, a dose-response relationship was reported for insecticide use per area of county 
land treated, but not for the amounts of restricted pesticides used or length of residency in a 
county prior to death (Ritz and Yu 2000).  
2.1.5 Analyses of quantitative measures of pesticides  
Finally, a few studies have assessed the link between pesticide exposure and PD by 
quantifying pesticide levels in PD patients. This has been tackled by measuring pesticides in 
both the serum and brain of deceased patients. A case-control study at the University of 
Texas Southwestern Medical Center collected serum samples from 50 PD patients and 43 
controls to quantify the levels of 16 organochlorine pesticides. Hexachlorocyclohexane was 
detectable in 76% of PD patients and 40% of controls. The higher frequency of detection in 
PD cases was significant (p < 0.05), as was the OR for the presence of this pesticide in serum 
predicting the diagnosis of PD (OR = 4.39; 95% CI 1.67-11.6). None of the other 15 
organochlorine pesticides showed detectable differences between controls and PD patients 
(Richardson et al. 2009). In addition, a study used organochlorine pesticide exposure data 
collected several years prior to the onset of PD as a potential biomarker for PD. Forty 
thousand two hundred and twenty-one serum samples of individuals aged ≥ 15 years were 
collected between 1968 and 1972 as part of a nested case-control study within the Finnish 
Mobile Clinic Health Examination Survey, and were analyzed in 2005–2007 for 
organochlorine pesticides. A total of 196 incident PD cases were identified during the 
follow-up in 1994 and were matched to 349 controls. Overall, 5 organochlorine pesticides 
were found at high levels, but only weak association emerged with this analysis. Only 
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increased dieldrin concentrations were associated with increased odds of PD (OR per 
interquartile range 1.95; 95% CI 1.26–3.02, p = 0.003) after adjustment for confounding 
factors (Weisskopf et al. 2010). Although this study presents an interesting design, with data 
collected prior to the development of PD, several limitations have to be taken into account. 
Serum samples were collected only once and reflect past pesticide exposure, but not 
exposure during the following decades. Importantly, exposure to pesticides with shorter 
half-lives that could have contributed to the pathology cannot be ruled out. 
The presence of organochlorines was also verified in post-mortem brain samples of 20 PD 
patients and 14 non-neurological control subjects. Of all the organochlorines measured, 
dieldrin and dichlorodiphenyltrichloroethane (DDT) were the only pesticides detected. 
Dieldrin was found in 6 out of 20 PD brains and in none of 14 control samples. The 
association between dieldrin and the diagnosis of PD was significant (p = 0.031) (Fleming et 
al. 1994). Others have analyzed organochlorine concentrations in brain areas more 
specifically affected by the pathology (e.g. caudate nucleus). There were indeed significantly 
higher concentrations of dieldrin in PD tissues as compared to controls (Corrigan et al. 
1998). The same group reported significantly higher levels of dieldrin and lindane in the 
substantia nigra (another structure largely affected by neuronal degeneration in PD) of PD 
patients as compared to nonparkinsonian controls (Corrigan et al. 2000).  
 
 
 
Fig. 2. Mapping of epidemiological studies assessing the relationship between pesticide 
exposure and the risk of developing Parkinson’s disease. Orange circles represent studies 
reporting a positive association between pesticide exposure and PD, whereas pink circles 
illustrate studies reporting a lack of association. Studies assessing the vulnerability of 
specific gene polymorphisms are represented by a yellow circle for a positive association, 
and a green circle for a lack of association. Double-colored circles depict positive or lack of 
associations in studies assessing both the risk of PD from pesticide exposure alone, or 
including genetic vulnerability. 
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2.2 Epidemiological studies targeting specific pesticides 
2.2.1 Organochlorines   
Organochlorines are cholinesterase inhibiting pesticides that were introduced on a large 
scale on the world market during the 60’s and 70’s. These compounds are classified as 
moderately (e.g. DDT, endosulfan, toxaphene), highly (e.g. aldrin, dieldrin, endrin) or 
extremely toxic (e.g. hexachlorobenzene) by the International Program of Chemical Safety of 
the World Health Organization. A case-control study of 380 PD patients recruited from nine 
German clinics, 379 neighborhood and 376 regional control subjects found a significantly 
elevated risk of PD for general pesticide use and for organochlorines (OR = 5.8; 95% CI 1.1-
30.4) and alkylated phosphates (OR = 2.5; 95% CI 1.3-4.6) in particular (Seidler et al. 1996). 
More recently, another group reported that organochlorine and organophosphorus 
pesticides were significantly associated with PD in a family-based case-control study 
involving 319 cases and 296 relatives and other controls, matched on genetic and 
demographic factors. Other controls were ascertained as spouses, unrelated controls or as 
related controls in families where no environmental risk factor data were available. PD 
patients reported significantly greater direct pesticide application/contact than their 
unaffected relatives (OR = 1.61; 95% CI 1.13–2.29). Furthermore, PD was associated with the 
highest frequency of exposure in both genders (OR = 2.15; 95% CI 1.06-4.35 for men and OR 
= 2.43; 95% CI 1.18-5.01 for women). A dose-response trend (OR = 2.47; 95% CI 1.12-5.44) 
and an association of PD with the lowest duration (p = 0.0058) were also reported, but only 
in women. Nevertheless, an association with PD was significant for the highest duration 
(OR = 2.70; 95% CI 1.35-5.40) and cumulative exposure (OR = 2.34; 95% CI 1.14-4.79), and 
significant dose-response trends were detected (p = 0.021 for duration and p = 0.036 for 
cumulative exposure). The latter associations were restricted to individuals without a family 
history of PD (Hancock et al. 2008). Moreover, a recent community-based case-control study 
examined the relationship between PD and pesticides in a population characterized by a 
high prevalence of exposure. Dose-effect analyses were performed using a cohort of 224 PD 
cases and 557 controls from the French Health Insurance (Mutualité Sociale Agricole) database 
for agricultural workers and related occupations. Twenty-nine pesticide families, based on a 
chemical classification, were analyzed in men exclusively. PD and overall professional 
pesticide use were positively associated (OR = 1.8; 95% CI 1.1-3.1), and a dose-effect 
relationship was found for the number of years of usage (p < 0.01). Insecticides were 
associated with PD (OR = 2.2; 95% CI 1.1-4.3), and more particularly insecticides belonging 
to the organochlorine family (OR = 2.4; 95% CI 1.2-5.0). In men with late-onset PD, these 
associations were more prominent (p < 0.01) and were characterized by a dose-effect 
relationship (Elbaz et al. 2009) (see Table 2 for details and Figure 2 for geographical 
mapping of studies conducted). 
An association between PD risk and exposure to several specific pesticides was reported in a 
study that enrolled individuals applying for certification for using restricted pesticides in 
Iowa and North Carolina. Data were obtained from licensed private pesticide applicators 
and spouses participating in the Agricultural Health Study Cohort. In this particular study, 
PD cases were selected based on self-report, thus the diagnosis was not confirmed by a 
neurologist. PD cases were compared with cohort members who did not report PD. The 
incidence of the disease was associated with cumulative days of pesticide use, applying 
pesticides themselves more than half of the time (OR 1/4 = 1.9; 95% CI 0.7-4.7). However, 
prevalence of PD was not associated with overall pesticide use. The investigators further 
www.intechopen.com
Pesticides and Parkinson’s Disease   
 
113 
observed elevated ORs for the prevalence of PD for the herbicides pendimethalin, paraquat, 
and cyanazine, and for the fumigants CS2/CCl4 and ethylene dibromide. ORs for incident 
PD were also elevated for the herbicides dicamba, trifuralin, 2,4,5-trichlorophenoxyacetic 
acid (2,4,5-T), and butylate, the insecticides lindane and phorate, the fungicides 
chlorothalonil and benomyl, and the fumigant CH3Br (Kamel et al. 2007). A more recent 
study employed a geographic information system that integrated data from California 
pesticide use reports and land-use maps (instead of surveys) to assess the degree and nature 
of pesticide exposure in PD patients to estimate potential well-water contamination with 
agricultural pesticides among 368 PD cases and 341 population controls who participated in 
the Parkinson’s Environment and Genes Study. The study investigated six different 
pesticides (diazinon, chlorpyrifos, propargite, paraquat, dimethoate and methomyl). 
Elevated levels of possible well-water contamination with methomyl (OR = 1.67; 95% CI 
1.00–2.78), chlorpyrifos (OR = 1.87; 95% CI 1.05–3.31), and propargite (OR = 1.92; 95% CI 
1.15–3.20) were associated with a 70 to 90% increase in RR of PD. They further showed that 
exposure to a higher number of water-soluble and organophosphate pesticides also 
increased the RR of PD in that cohort (Gatto et al. 2009). Another recent study employed a 
multicenter case-control study design involving 8 movement disorder centers in North 
America to evaluate the relationships between occupations, specific job tasks, or exposure 
and the risk of parkinsonism. Five-hundred nineteen PD patients and 511 controls that were 
primarily non-blood relatives, or acquaintances, participated in the study. Pesticide use was 
associated with an elevated risk of parkinsonism (OR = 1.90; 95% CI 1.12-3.21, p = 0.02). In 
addition, the use of any of the 8 pesticides selected a priori as presenting a particular interest 
to the development of animal models of PD (2,4-dichlorophenoxyacetic acid (2,4-D), 
paraquat, permethrin, dieldrin, diquat, maneb, mancozeb and rotenone; cf. section 2.3) also 
increased the risk of parkinsonism (OR = 2.20; 95% CI 1.02-4.75. p = 0.04). 2,4-D was the only 
pesticide significantly associated per se with an increased risk for PD (2.59; 95% CI 1.03-6.48 
p = 0.04) (Tanner et al. 2009). 
2.2.2 Paraquat, maneb and rotenone  
Some epidemiological studies have gone further with their analyses, isolating specific 
classes of pesticides or individual pesticides to determine their possible influence on the 
probability of developing PD. One of these pesticides is paraquat, a contact herbicide 
belonging to the heterocyclic quaternary ammonium family and a very potent, self-
regenerating oxidizing agent and photosynthesis inhibitor which is widely used in 
agriculture, based in part on the fact that it acts quickly and is characterized by a short 
bioavailability. A first report was based on 57 PD cases and 122 age-matched, randomly 
selected controls from regional electoral rolls, all < 80 years of age, where four PD patients 
and no controls reported paraquat contact. Although an OR could not be calculated (no 
exposed controls), a Fisher’s exact test gave a significant probability estimate of 0.01 for the 
association between paraquat contact and development of PD (Hertzman et al. 1990). Over 
120 PD cases recruited from the Movement Disorder Clinic of the National Taiwan 
University Hospital in Taipei and 240 hospital controls recruited from the neurological or 
medical outpatient clinics at the same hospital, 28 PD cases and 18 control subjects reported 
having been previously exposed to paraquat. In the univariate analysis, the use of herbicides 
and pesticides (OR = 2.89; 95% CI 2.28-3.66, p < 0.01), and the use of paraquat (OR = 3.22; 
95% CI 2.41-4.31, p < 0.01) were associated with an increased PD risk that also followed a 
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dose-response relationship. The biological gradient between PD and the previous use of 
herbicides and pesticides, and paraquat specifically, remained significant even after 
adjusting for multiple risk factors. Of note, there was a greater risk of developing PD for 
subjects who had used paraquat and other herbicides/pesticides than for those who had 
used herbicides/pesticides but not paraquat (Liou et al. 1997).  
Considering that the geographical distribution of paraquat and maneb overlaps in several 
areas of the USA, their potentially synergistic neurotoxic effects have been more closely 
examined. Both compounds are similarly applied, but paraquat has a much longer half-life 
than maneb. Costello and coll. have reported that exposure to paraquat and maneb within 
500 m of the residence increased PD risk by 75% (OR 1/4 = 1.75; 95% CI 1.13-2.73), using the 
geographic information system that integrated data from the California pesticide use reports 
and land-use maps reported by Gatto et al. (2009). This study incorporated 368 idiopathic 
PD cases and 341 population controls from the Central Valley of California. The authors also 
evaluated PD risk for two separate periods of pesticide exposure (between the years 1974–
1989 and 1990–1999). The risk of developing PD was higher in younger subjects or when 
exposed at a younger age to either maneb or paraquat alone (OR 1/4 = 2.27; 95% CI 0.91-
5.70) or to both pesticides in combination (OR 1/4 = 4.17; 95% CI 1.15-15.16) (Costello et al. 
2009) (see Table 2 for details and Figure 2 for geographical mapping of studies conducted).  
More recently, a case-control study in eastern Texas recruited 100 PD cases and 84 controls, 
and observed a strong association between the risk for PD and the use of organic pesticides 
such as rotenone within the past year of gardening (OR = 10.9; 95% CI 2.5-48.0, p < 0.001) 
and any rotenone use in the past (OR = 10.0; 95% CI 2.9-34.3, p <0.001). Exposure to several 
other pesticides was also evaluated, and an elevated risk was associated with domestic use 
of chlorpyrifos products (OR = 2.0; 95% CI 1.02-3.8, p = 0.043). A possible association of 
increased PD risk with the domestic use of paraquat was also observed, but did not reach 
statistical significance (Dhillon et al. 2008). 
2.3 Evidence from animal studies 
2.3.1 Paraquat- and maneb-induced animal models of Parkinson’s disease 
If epidemiological studies have left a rather confusing picture of the contribution of 
pesticides to PD, basic research has also addressed the question by attempting to duplicate 
the clinical and pathological signs of PD in both petri dishes and small laboratory animals. 
The following section is devoted to some in vitro, but particularly in vivo work performed in 
rodents in the hope of shedding light on the role of environmental toxins, such as pesticides, 
to the development of a syndrome resembling human parkinsonism.  
It has been suggested that dopaminergic cell degeneration observed in PD is consequential to 
the toxic accumulation and aggregation of proteins, mitochondrial dysfunction and oxidative 
stress. The neurotoxicity of paraquat resides within its strong redox cycling properties that 
leads to its transformation to the reduced paraquat radical which is then readily reoxidized by 
O2, thereby generating reactive oxygen species, including superoxide anions (O2-) (Autor 1977; 
Bus et al. 1974; Jones and Vale 2000). The oxidative stress thus generated is believed to cause 
lipid peroxidation, inhibition of complex I in the mitochondrial respiratory chain, as well as 
cell death. Several animal studies have reported that paraquat can cause dopaminergic 
neuronal degeneration, the vast majority of which used a systemic paraquat administration 
approach  [e.g.: (Brooks et al. 1999; Fredriksson et al. 1993; Kang et al. 2009; Kuter et al. 2007; Li 
et al. 2005; Peng et al. 2004; Shimizu et al. 2003; Somayajulu-Nitu et al. 2009; Tawara et al. 
www.intechopen.com
Pesticides and Parkinson’s Disease   
 
115 
1996)]. Systemic administration of paraquat can also produce motor deficits such as decreased 
locomotor activity, reduced spontaneity in gait performance, and impaired pole test 
performance (Brooks et al. 1999; Li et al. 2005; Somayajulu-Nitu et al. 2009), and can induce the 
upregulation and aggregation of α-synuclein in the substantia nigra of wild-type mice 
(Manning-Bog et al. 2002). Although this model – as any animal model of human diseases – 
does not entirely mimic the human pathology, studies of paraquat-induced parkinsonism in 
animal models have provided valuable information with regards to the potential mechanisms 
involved in neurodegenerative processes associated with environmental toxicity. Pathological 
observations made in animal models thus imply that paraquat is unlikely a single contributor 
to the etiology of PD.  
One of the most compelling findings of animal studies has derived from using combination 
of paraquat and maneb. Indeed, combined administration of both compounds to rodents 
has been useful to demonstrate the potential synergistic effects of environmental 
compounds in reproducing some features of PD in animals. In addition to causing 
nigrostriatal dopaminergic depletion [e.g. (Cicchetti et al. 2005; Drouin-Ouellet et al. 2007; 
Saint-Pierre et al. 2006; Thiruchelvam et al. 2000a; Thiruchelvam et al. 2003a; Thiruchelvam 
et al. 2000b)], the paraquat and maneb combination has also been shown to potentiate α-
synuclein-induced toxicity (Norris et al. 2007; Thiruchelvam et al. 2004). Moreover, systemic 
administration of paraquat and maneb induces motor impairments reminiscent of PD.  
Two studies have further explored the effect of a developmental exposure to paraquat and 
maneb followed by a re-challenge latter in adult life. Early postnatal exposure to the 
combination of compounds generated a decrease in activity, striatal dopamine depletion 
and dopaminergic cell loss in the substantia nigra. An adult re-challenge of the paraquat/ 
maneb combination showed an even more striking decrease in locomotor activity, striatal 
dopamine levels, and dopaminergic cell loss. While postnatal exposure to paraquat or 
maneb alone produced minimal changes in adulthood, a re-challenge at that time unveiled a 
quiescent toxicity due to these pesticides (Thiruchelvam et al. 2002). Another study assessed 
whether in utero exposure to paraquat and maneb would interfere with the development of 
the nigrostriatal dopaminergic pathway and enhance its vulnerability to dopaminergic 
neurotoxicant exposures in adulthood. Only males exposed to maneb prenatally and to 
paraquat in adulthood displayed significant decrease in locomotor activity, changes in 
striatal dopamine and selective dopaminergic neuronal loss in the substantia nigra (Barlow 
et al. 2004). The results obtained with the paraquat- and maneb-induced animal model have 
provided support for a multi-hit hypothesis in PD pathogenesis and recapitulate most 
epidemiological studies assessing this particular hypothesis, although the routes of delivery 
employed (mainly intraperitoneal (i.p.) and subcutaneous (s.c)) remain unrepresentative of 
human exposure. Taken together, research shows 1) an age-related propensity to incur 
degeneration of the nigrostriatal pathway in response to toxin (herbicide, pesticide, 
fungicide) exposure (Thiruchelvam et al. 2003b; Thiruchelvam et al. 2002), and 2) an 
exacerbation of nigrostriatal pathology by double-exposure whereby early (prenatal, 
postnatal) contact with these toxins predispose older animals to the effects of re-exposure to 
the toxins (Carvey et al. 2003; Ling et al. 2002; Thiruchelvam et al. 2002). The mechanism for 
the increased sensitivity to toxins in adults and/or re-exposed animals is to date unknown. 
2.3.2 Rotenone-induced animal models of Parkinson’s disease 
Unlike quaternary amines like paraquat or diquat, rotenone crosses the blood-brain barrier 
due to its lipophilic attributes. This insecticide has been targeted as a potentially active agent 
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in PD pathogenesis based on its ability to inhibit complex I of the mitochondrial respiratory 
chain, which triggers the production of reactive oxygen species and the activation of 
mitochondria-dependent apoptotic molecular pathways. This subsequently leads to 
oxidative damage targeting proteins, lipids and DNA, ultimately leading to dopaminergic 
cell death (Dauer and Przedborski 2003; Vila and Przedborski 2003). Mutations in specific 
genes linked to mitochondrial proteins have also been associated with some familial forms 
of PD (Bueler, 2009). However, the specific mechanism involved in the enhanced 
vulnerability of nigral dopaminergic neurons to rotenone is still undeciphered. In 
opposition, an in vitro study has suggested that complex I inhibition might not be necessary 
for dopaminergic neuronal death (Choi et al. 2008). Nevertheless, rotenone has been 
suggested to act as a proteosome inhibitor (Chou et al. 2010; Wang et al. 2006b). 
The most studied rotenone-induced animal model of PD involved a chronic mode of 
intravenous (i.v.) delivery via osmotic minipumps, although other delivery methods have 
also been explored, including i.p., and s.c. osmotic minipumps as well as intranasal and oral 
routes. In the vast majority of these studies, the substantia nigra dopaminergic neurons were 
affected, in addition to other types of neurons within the striatum. Several studies have 
reported that rotenone administration generated motor deficits reminiscent of several 
clinical features of PD such as hypokinesia, rigidity, hunched posture, unsteady movements, 
prolonged descent latency as well as resting tremors [e.g. (Alam et al. 2009; Alam et al. 2004; 
Alam and Schmidt 2004; Betarbet et al. 2000; Hoglinger et al. 2005; Luo et al. 2007; Pasha et 
al. 2005; Richter et al. 2007; Sherer et al. 2003; Tapias et al. 2009)]. Moreover, ubiquitin and α-
synuclein aggregates were detected in striatal and nigral neurons in animals challenged 
with rotenone [e.g. (Betarbet et al. 2006; Cannon et al. 2009; Hoglinger et al. 2005; Inden et al. 
2007; Luo et al. 2007; Monti et al. 2009; Takeuchi et al. 2009)]. As for paraquat and maneb-
induced animal models of PD, rotenone induces peripheral toxicity leading to a high 
mortality rate, a phenomenon that does not resemble the human form of the disease (see 
review Cicchetti et al. 2009; Lapointe et al. 2004).  
The mode of administration of rotenone employed in most animal studies does not mimic 
the route of exposure experienced in humans, as it is more likely that rotenone gains access 
to the brain via direct exposure of neurons in the gut and/or olfactory regions, i.e. the only 
nervous system structures directly exposed to environmental compounds (Lerner and Bagic 
2008). One study administered rotenone intranasally daily for one month at a dose range 
similar to that used in i.p., i.v., and s.c. delivery studies, but reported no change in the 
nigrostriatal dopaminergic system and no behavioral alterations. A few studies have also 
explored the oral route of administration of rotenone and have observed degeneration of 
dopaminergic cells and their terminals. All of these studies also reported an upregulation or 
aggregation of α–synuclein accompanied with motor impairments (Inden et al. 2007; Inden 
et al. 2009; Pan-Montojo et al. 2010; Takeuchi et al. 2009). One of these studies administered 
rotenone intragastrically and observed α–synuclein accumulation and aggregation first at 
the periphery, and then in structures of the central nervous system affected in PD (Pan-
Montojo et al. 2010). This reflects, to some extent, the course of the PD pathogenesis, where 
the synucleinopathy is restricted to the peripheral organs at the presymptomatic stages, 
whereas at latter stages, the substantia nigra and other nuclei of the midbrain and forebrain 
display similar pathological changes (Braak et al. 2003). The effect of chronic oral 
administration of rotenone to transgenic mice overexpressing human α–synuclein was also 
investigated. Despite increased cytoplasmic expression of α–synuclein and PINK1, along 
with decreased spontaneous locomotor movements induced by rotenone, no change in brain 
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dopamine levels or nigrostriatal cell loss was observed. The authors concluded that this 
model could mimic presymptomatic PD features and compensatory changes in early PD 
stages (George et al. 2010).  
2.3.3 Animal model of Parkinson’s disease induced by other pesticides 
Most of the studies pertaining to the effects of various pesticides, especially organochlorines, 
have demonstrated some dopaminergic alterations within the nigrostriatal system (Miller et 
al. 1999; Pittman et al. 2003; Schuh et al. 2009), while others have failed to report such 
changes (Hatcher et al. 2008; Thiffault et al. 2001). However, results do suggest that 
developmental or adult exposure to dieldrin increases the vulnerability of nigrostriatal 
dopaminergic neurons by persistently altering the development of the dopaminergic 
system, or by inducing oxidative stress (Hatcher et al. 2007; Richardson et al. 2006). When 
probing other pesticides such as heptachlor, endosulfan and zineb, studies have shown their 
detrimental effect on the development of the dopaminergic system, subsequently leading to 
an increased vulnerability in adulthood (Caudle et al. 2005; Jia and Misra 2007; Richardson 
et al. 2008). Taken together, these studies suggest that developmental pesticide exposure 
causes long-term alterations of the dopaminergic system thereby rendering it more 
susceptible to dopaminergic damage in adulthood. Longitudinal epidemiological studies 
assessing the effect of pesticide exposure during the developmental stages would be of high 
relevance to evaluate the impact of such exposure on neurological disorder development in 
adulthood. 
3. Genes and pesticide exposure 
Although 90-95% of PD cases are of unknown etiology, 5-10% of patients are known to have 
monogenic forms of the disease. To date, 13 loci and 9 genes are associated with both 
autosomal dominant (e.g. α-synuclein, ubiquitin C-terminal hydrolase L1 (UCHL1), LRRK2, 
GIGYF2, Omi/Htra2) and autosomal recessive (e.g. parkin, PINK1, DJ-1, ATP13A2) PD, but 
additional genes have also been associated with the disease. Genes may also play a role in 
the sporadic form of PD, given the role of the encoded proteins in various important cellular 
functions such as in mitochondrial (e.g. α-synuclein, parkin, PINK1, Omi/HtrA2, DJ-1, 
POLG1) and lysosomal (e.g. α-synuclein, ATP13A2, GBA) functions, protein degradation 
(e.g. parkin, UCHL1, α-synuclein), developmental regulation (e.g. α-synuclein, parkin, 
UCHL1, LRRK2, Omi/HtrA2, Nurr1, PITX3, various microRNAs, etc.), and their 
localization at the synapse (e.g. α-synuclein, parkin, LRRK2, UCHL1, synphilin, etc.) (for a 
review, see Biskup 2008) (see Table 3 for details and Figure 2 for geographical mapping of  
studies conducted). Alterations in these proteins contribute to the pathological features 
encountered in the different forms of PD. 
3.1 Susceptibility genes involved in the metabolism of pesticides  
In recent years, a subset of epidemiological studies has thus focused on investigating a 
potential association between candidate genes for susceptibility to PD and exposure to 
pesticides. The first gene polymorphisms that have been studied code for glutathione-S-
transferases (GSTs), which are a ubiquitous group of detoxification enzymes involved in the 
metabolism of several toxins, including pesticides, and that can protect cells against 
oxidative stress (Di Ilio et al. 1995). Using a cohort of 95 PD and an equal number of control 
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subjects, four GST classes were genotyped (GSTM1, GSTT1, GSTP1, and GSTZ1). In subjects 
who had been exposed to pesticides, there was a significant difference in GSTP1 genotype 
between PD patients and controls (p = 0.009), but other GST polymorphisms did not show 
any association with PD (Menegon et al. 1998). A second study assessed the relationship 
between GST polymorphisms, PD and pesticide exposure in a multicenter study of paired 
relatives diagnosed with PD, designed for genetic linkage analyses. Seven single-nucleotide 
polymorphisms (SNPs) were genotyped in the GSTP1 class, of which 3 were connected to 
the age of onset in the group of men occupationally exposed to herbicides. Significant trends 
were observed in the herbicide exposure group for the association of age of PD onset for 
three additional SNPs. The authors also reported that herbicide exposure modified the 
association between GSTP1 and the age of onset. Furthermore, one haplotype was 
associated with earlier onset of PD (7.93 years) in the occupationally exposed group (p = 
0.008) and a later PD onset (2.82 years) in the non-exposed group (p = 0.048) (Wilk et al. 
2006). GSTP1 is expressed at the level of the blood-brain barrier and could influence the 
response to neurotoxins such as pesticides, by offering protection against the oxidative 
damage that is hypothesized to play a role in PD pathogenesis. However, another study 
failed to corroborate these results and reported that seven GST polymorphisms were in fact 
not associated with PD, nor was pesticide use (238 Japanese PD cases and 370 controls). In 
this particular study, controls were not matched to cases, which led to a significant 
difference between the age of subjects (controls being younger than cases) and the number 
of pesticide users was small, which gave negligible power to the analysis (Kiyohara et al. 
2010). 
Similar analyses were conducted to probe the potential association between PD and the 
organophosphates diazinon, chlorpyrifos, and parathion, and the influence of a functional 
polymorphism at position 55 in the coding region of the PON1 gene (PON1-55). This gene 
codes for paraoxonase, an enzyme which hydrolyzes organophosphates and predicts the 
susceptibility of an individual to these compounds, more particularly the insecticides 
diazinon and chlorpyrifos (Costa et al. 2003). Exposure to chlorpyrifos was associated with 
an increased risk of PD, both at low and high frequency levels of exposure, and more 
prominently among people over 60 (OR = 2.65; 95% CI 1.19-5.90). An association between 
PD and high, but not low levels of diazinon exposure, was also reported, but not with 
parathion. Within subjects exposed to organochlorines, carriers of the variant MM PON1-55 
genotype displayed an increased risk of PD compared with subjects carrying the wild-type 
or heterozygous genotype and without a history of exposure (diazinon, OR = 2.2; 95% CI 
1.1-4.5; chlorpyrifos, OR = 2.6; 95% CI 1.3-5.4). Additionally, the effect estimate for 
chlorpyrifos was greater in earlier-onset cases and controls (≤ 60 years of age; OR = 5.3; 95% 
CI 1.7-16), but no increase in PD risk was noted for parathion (Manthripragada et al. 2010). 
In a larger case-control study, Dick and colleagues (2007) investigated the interactions 
between several polymorphic genes that metabolize foreign chemicals, metabolize or 
transport dopamine and that occur relatively frequently in the European population 
(CYP2D6, PON1, GSTM1, GSTT1, GSTM3, GSTP1, NQO1, CYP1B1, MAO-A, MAO-B, SOD2, 
EPHX, DAT1, DRD2 and NAT2), exposure to solvents, pesticides and metals, and risk of PD. 
Nine hundred and fifty-nine prevalent cases of parkinsonism (767 with PD) and 1 989 
control subjects were recruited from five European centers. Parkinsonism was modestly, but 
significantly associated with MAO-A polymorphism in males (G vs. T, OR = 1.30; 95% CI 
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1.02-1.66, adjusted for confounding factors). Although a possible interaction between a 
GSTM1 null genotype and solvent exposure was shown, other gene-environment 
interactions failed to show any significant association (Dick et al. 2007). 
3.2 Susceptibility genes involved in pesticide transport to the brain 
The multidrug resistance protein 1 (MDR1 or ABCB1) gene encodes an integral membrane 
glycoprotein expressed in various tissues, including the blood-brain barrier, and which 
regulates brain penetration of a wide range of endogenous molecules and xenobiotics, 
including several pesticides such as organochlorines (Bain and LeBlanc 1996). In a case-
control study, Zschiedrich and coll. (2009) evaluated the potential relationship between 
ABCB1 variants and PD in relation to pesticide exposure in 599 PD patients and control 
subjects. Despite the fact that ABCB1 was not associated with PD in this particular study, a 
different genotype distribution was observed between patients exposed to pesticides 
compared to non-exposed patients (OR = 4.74; 95% CI 1.009-22.306, p = 0.047), suggesting 
that common ABCB1 variants may interact with pesticide exposure to influence PD risk 
(Zschiedrich et al. 2009). A second study evaluated the association between two 
polymorphisms in ABCB1, PD and organochlorine insecticide exposure among 207 cases 
and 482 matched control subjects enrolled in the French health system for agricultural 
workers described previously (Elbaz et al. 2009). As for the study of Zschiedrich and coll. 
(2009), ABCB1 polymorphisms were not associated with PD. However, the OR for 
organochlorines was 3.5 (95% CI 0.9-14.5) times higher among homozygous carriers of 
variant G2677 (A,T) alleles than noncarriers. The case-only analysis uncovered an 
association between carrying two variant G2677 (A,T) alleles and organochlorines (OR = 5.4; 
95% CI 1.1-27.5), as well as with the number of cumulative lifetime number of hours of 
exposure (overall, p = 0.005; analyses restricted to subjects exposed to organochlorines, p = 
0.03) (Dutheil et al. 2010). 
3.3 Susceptibility genes involved in elimination of toxic compounds derived from 
pesticides 
A case-control study evaluated the role of manganese-containing superoxide dismutase 
(MnSOD) and NAD(P)H: quinone oxidoreductase 1 (NQO1) genes with PD risk in a 
southwestern Taiwanese population with a high prevalence of pesticide exposure. MnSOD 
is an enzyme that converts superoxide anions (O2-) into hydrogen peroxide (H2O2) and 
dioxygen (O2). Suppressing free radicals within mitochondria protects against the 
detrimental effects of oxidative stress on cell integrity. In Japanese patients with familial PD, 
the MnSOD C allele is significantly related to the disease (Shimoda-Matsubayashi et al. 
1997). NQO1 is also an enzyme that reduces several neurotoxic quinonoid compounds, 
which leads to protection of the cells against reactive oxygen species damage during redox 
cyclic processes (Chen et al. 2000). The genotypes of MnSOD (−9 TNC) and NQO1 (609 CNT) 
genes were determined among the 153 patients with idiopathic PD and 155 matched healthy 
controls. After adjustment for confounding factors, a significant association was found 
between pesticide exposure and PD risk (OR = 1.68; 95% CI 1.03-2.76, p = 0.023). In this 
population, MnSOD and NQO1 polymorphisms were not associated with increased PD risk, 
but there was a significant difference in genotype distribution among subjects exposed to 
pesticide for the MnSOD C allele (OR = 2.49; 95% CI 1.18-5.26, p = 0.0072) and for the NQO1 
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T allele (OR = 2.42; 95% CI 1.16-4.76, p = 0.0089). Furthermore, a significant association was 
reported between the combined MnSOD/NQO1 variant genotype among subjects exposed to 
pesticides and increased PD risk (OR = 4.09; 95% CI 1.34-10.64, p = 0.0052) (Fong et al. 2007).  
3.5 Susceptibility genes targeted in Parkinson’s disease  
Two studies have examined the possible interaction between the dopamine transporter 
(DAT) gene (SLC6A3), of which eight haplotypes have been identified (grouped into two 
evolutionary clades (A and B)), and PD risk after pesticide exposure. In a case-control study 
of 293 cases and 395 controls that were classified by the number of risk alleles, a significant 
interaction between occupational pesticide exposure in men and the number of risk alleles 
was reported, the OR for having two or more risk alleles reaching 5.66 (95% CI 1.73–18.53) 
among subjects exposed to pesticides (Kelada et al. 2006). A subsequent study 
independently investigated the genetic variability in the DAT locus in 324 incident PD cases 
and 334 controls from the rural California case-control study using the previously described 
geographic information system for pesticide exposure evaluation (Costello et al. 2009; Gatto 
et al. 2009). Two SNPs were genotyped for the DAT 5´ A clades and the 3´ variable number 
of tandem repeats (VNTR), the susceptibility alleles being defined as the 5´ A clade and the 
3´ VNTR 9-repeat. Carriers of one susceptibility allele who were highly exposed to paraquat 
and maneb had an increased PD risk (OR = 2.99; 95% CI 0.88-10.2), and this was more 
prominent in those with two or more alleles (OR = 4.53; 95% CI, 1.70-12.1). Similar results 
were also obtained for occupational pesticide analysis (Ritz et al. 2009).  
Furthermore, it has been suggested that SNPs might lead to slight alterations in the PINK1 
gene and might play an important role in the development of sporadic late-onset PD (Wang 
et al. 2006a). In a study with 48 PD cases and 61 controls from Brazil carrying PINK1 SNPs, 
31.3% and 39.4% presented the PINK1 SNP IVS1−7 A→G polymorphism, respectively. 
Exposure to various environmental risk factors (living in rural areas, well-water drinking, 
and exposure to pesticides, herbicides or organic solvents) in collaboration with PINK1 SNP 
IVS1−7 A→G polymorphism had a significant effect in lowering the age of PD onset, 
whereas when singling out exposures to the various environmental factors, no association 
was found between such exposures, PINK1 SNP IVS1−7 A→G polymorphism and PD 
(Godeiro et al. 2010). 
A case-control study with 833 case-control pairs further examined the possible interaction 
between SNCA REP1 genotypes (coding for α-synuclein), which have been shown to confer 
susceptibility to sporadic PD, and pesticide exposure on the risk of PD in human. This 
epidemiological study did not find any interaction between the SNCA REP1 genotype and 
herbicides, although both SNCA REP1 score (OR = 1.18; 95% CI 1.02-1.37; p = 0.03) and 
pesticide exposure were significantly associated with PD in younger subjects (≤ 59.8 years of 
age; OR = 1.80; 95% CI 1.12-2.87; p = 0.01 for all pesticides; OR = 2.46; 95% CI 1.34–4.52; p = 
0.004 for herbicides) (Brighina et al. 2008).  
Taken together, the results of the gene-environment epidemiological studies converge 
toward an influence of certain gene polymorphisms on the effect of exposure to at least 
some pesticides on PD and its onset. They further suggest that individual genetic 
susceptibility may affect the outcome of epidemiological studies. This is a very likely 
explanation for the inconsistent results reported thus far and needs to be taken into account 
when reviewing past studies on the effect of pesticide exposure and PD risk.  
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4. Conclusion 
Numerous challenges must be faced in interpreting epidemiological studies, as illustrated in 
this chapter. Data gathered thus far originate from various approaches, which include case 
reports, mortality studies (geographical analysis of death certification), ecological studies 
(e.g. analyzing pesticide exposure from levels detected in the environment), case-control 
and cohort studies. The discrepancies in the results obtained with epidemiological studies 
are largely due to issues related to the methodological approaches utilized, case 
ascertainment, selection of controls and diagnostic criteria, all factors likely to introduce 
bias. Most methodologies employed are based on self-surveys and recall of chemical usage, 
which can be particularly precarious when collected from patients suffering from 
neurodegenerative disorders. Furthermore, questionnaires used to determine the type and 
length of pesticide exposure may vary significantly among studies - with the accuracy for 
self-reported pesticide exposure being high for broad categories and commonly employed 
pesticides, but not for specific pesticides (Engel et al. 2001b). Unbiased selection of controls 
is also of utmost importance but may be challenging. Controls and cases may be recruited 
from the general population or be hospital-based, which can result in selection bias for both 
cases and controls if participation is influenced by factors such as disease severity, personal 
income, cultural differences and geographic location. Control subjects are very often 
relatives or friends of the subjects, allowing for the possibility of similar exposure history 
and thus invalidating the risk estimate due to bias.  
Misdiagnosis remains frequent in PD, especially in the early stages of the disease, and can 
thus have a significant impact on the outcomes of clinical and epidemiological studies 
(Litvan et al. 2003). A single causative factor might also be difficult to identify, because such 
a factor may differ among patients with different clinical manifestations. Stratifications of 
clinical subsets (e.g. age of onset, progression, motor symptoms, etc.) may help identify 
environmental causes of PD. Several elements, such as age, family history of PD, earlier 
head trauma due to accidents, smoking habits, caffeine consumption and infectious 
diseases, as well as environmental factors including well-water drinking and farming, have 
all been suggested to play a role in the incidence of PD, and can be sources of confounding 
factors. All of these potential biases may pose a significant hurdle in evaluating the actual 
contribution of pesticide exposure to PD. Despite accumulating evidence supporting the 
hypothesis that pesticide exposure may be responsible for the etiology of PD, at least in a 
subset of cases, the overall picture remains inconclusive but at least convincing enough to 
justify the debate to be pursued and the issue to be clarified.  
Future research should focus on understanding how combining compounds that target 
different cellular functions might work cooperatively to also cause neuronal damage. As 
challenging as this task might be, pesticide properties, such as biological availability, 
persistence in the environment as well as application methods that can lead to widespread 
exposure, should be taken into account when evaluating the potential of a pesticide to 
participate to PD pathogenesis. In addition, genetic vulnerability is likely a key player in the 
outcome of pesticide exposure. In that regard, more studies are clearly needed to target 
specific polymorphisms. Finally, epidemiological studies have thus far provided rather 
disparate and somehow incoherent results, and segregation of different PD subtypes, as 
well as better methodologies with regard to the evaluation of pesticide exposure, might help 
in pinpointing the involvement of specific compounds in PD incidence and provide us with 
tools to design and develop drug targets to prevent PD pathogenesis. 
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